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Background:  Several studies have demonstrated that ephedrine shortens the onset time of muscle relaxants, and 
it does so probably by increasing the cardiac output. However, elevation of the systemic blood pressure through α 
adrenergic stimulation via ephedrine may affect the onset of muscle relaxants during the induction of anesthesia. We 
investigated the effect of phenylephrine, which is a selective α-1 agonist, on the onset time of rocuronium and the 
intubating conditions in adults after the administration of propofol. 
Methods:  Sixty-four patients were randomly assigned to two groups. Phenylephrine (0.9 μg/kg) (P group) or the 
same volume of saline (S group) was injected before rocuronium (0.6 mg/kg) administration. Anesthesia was induced 
with fentanyl 2 μg/kg and propofol 2 mg/kg. The onset time was defined as the time from the end of rocuronium 
injection to the time when a single twitch height gets to 0% or the minimum level. A well-trained anesthesiologist 
who was ‘blinded’ to the treatment groups evaluated the intubating conditions. The mean arterial pressure and heart 
rate were recorded before induction, before intubation, immediately after intubation and 1 minute and 2 minutes 
after intubation.
Results:  The onset time was 84 ± 18 sec in the P-group and 72 ± 14 sec in the S-group. There was no difference of the 
intubating conditions, the mean arterial pressure and the heart rate between the two groups. 
Conclusions:  A small dose of phenylephrine, which has a limited effect on blood pressure, delayed the onset time 
of rocuronium after the administration of propofol, and the vasoconstriction effect of phenylephrine may affect the 
prolongation of the rocuronium onset time at the induction of anesthesia with using propofol. (Korean J Anesthesiol 
2010; 59: 244-248)
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Introduction 
    During the rapid sequence induction of general anesthesia, 
the use of a muscle relaxant with a rapid onset time and short 
duration is crucial to reduce the risk of hypoxia and aspiration 
pneumonia. Although succinylcholine is an excellent choice 
for the purpose, its many potential complications has led to 
searching for an alternative. In addition to the development 
of a new muscle relaxant for rapid tracheal intubation, efforts 
have been made to use the existing non-depolarizing muscle 
relaxants by reducing their onset time. 
    To reduce the onset time, many studies were focused on 
modifying hemodynamic factors such as the cardiac output, 
the circulation time and the muscle blood flow [1]. Researchers 
have suggested that a non-depolarizing muscle relaxant may 
act more rapidly on the neuromuscular junction through 
increased cardiac output and muscle blood flow because the 
agent injected in the vein may reach to the neuromuscular 
junction more rapidly. Ephedrine was reported by several 
studies to reduce the onset time of rocuronium, which is a non-
depolarizing muscle relaxant, by increasing the cardiac output 
via the β-adrenergic receptor [2-5]. On the other hand, esmolol, 
which is a β adrenergic antagonist, was reported to prolong the 
onset time of rocuronium [2,5]. 
    The above mentioned studies on ephedrine focused on its 
β-adrenergic agonist effect. However, ephedrine is a weak, 
indirect and direct-acting sympathomimetic agent with both α- 
and β-adrenergic agonist effects. When ephedrine is used after 
bolus administration of an anesthetic agent, its α-1 arteriolar 
constriction action as well as its β-adrenergic agonist action 
prevents hypotension caused by vasodilation and decreased 
cardiac output. Therefore, the α-adrenergic agonist effect of 
ephedrine may affect the change in the onset time of a non-
depolarizing muscle relaxant. 
    This study was designed to evaluate the effect of an α-adren ergic 
agonist on the onset time of rocuronium by using the direct 
acting α-adrenergic agonist phenylephrine. The changes in the 
hemodynamic parameters and the duration of rocuronium’s 
action were also evaluated. 
Materials and Methods
    This study was approved by the hospital ethics committee and 
written informed content was obtained from all the patients. 
Sixty-four patients with an ASA physical status I or II, an age 
from 15 to 65 years and who were scheduled for elective general 
surgery were enrolled in this prospective, randomized, double 
blinded study. 
    The patients were randomly allocated to either the phenyle-
phrine group (P group) or the normal saline group (S group) 
using a computer generated randomization list in a sealed 
envelope. The exclusion criteria included an anticipated 
difficult airway, pregnancy, a neuromuscular disorder, hyper-
tension, cardiovascular disease and renal disease. Those pati-
ents taking drugs that have an influence on phenylephrine or 
neuro muscular blocking agents and those with known allergy 
to the drugs used in this study were also excluded. The study 
syringe containing 5 ml of phenylephrine 0.9 μg/kg diluted with 
saline 0.9% (the P-group) or the same volume of normal saline 
(the S-group) was prepared by an independent researcher. 
The dose of phenylephrine was based on a previous study that 
used ephedrine to shorten the onset time of rocuronium, and 
that study reported 70 μg/kg as the dose that can minimize 
the adverse cardiovascular effect [2,4]. Then the dose of 
phenylephrine was calculated at the potency ratio of 80 to 1 
based on the study by Saravanan et al. [6]. 
    All the patients were fasted for at least 8 hr for solid food 
and 3 hr for clear fluid. The patients were premedicated with 
Fig. 1. Schematic diagram of the process 
of the experiment. Phenylephrine 
or saline was given 40 sec before the 
administration of rocuronium. The 
onset is the time interval from the end of 
rocuronium injection to 0% or the maxi-
mal depression of a single twitch height. 
The duration is the time interval from 
maximal depression of a twitch height 
to the 10% recovery of a twitch height.
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midazolam 2 mg by intramuscular injection 30 min before 
induction of general anesthesia. On arrival in the operation 
room, standard monitoring that included ECG, pulse oximetry 
and non-invasive blood pressure was instituted. All the 
patients were pre-oxygenated with 100% O2 for 3 minutes. An 
intravenous bolus of fentanyl 2 μg/kg was injected and the 
neuromuscular monitoring was calibrated. The study drug was 
injected 3 minutes after fentanyl administration and 10 sec 
after the study drug injection, 2 mg/kg of propofol was given 
over 20 sec. Rocuronium 0.6 mg/kg was administered another 
10 sec later. Just before the administration of the propofol, 
neuromuscular monitoring was started with square wave, 1.0 
Hz supramaximal single twitch monitoring using TOF-WatchⓇ
(Organon Teknica B.V., Boxtel, The Netherlands) on the ulnar 
nerve of the arm (Fig. 1). The neuromuscular function of the 
ulnar nerve was assessed using surface eletrodes and the 
resulting force of contraction of the adductor pollicis longus 
muscle was continuously measured. The onset time was defined 
as the time from the end of rocuronium administration to the 
maximum twitch depression. After the intubation, single twitch 
monitoring was converted to continuous TOF monitoring and 
the duration of action was defined as the time from the end 
rocuronium administration to the 10% recovery of the T1 twitch 
height [7]. 
    The trachea was intubated within 20 sec of 0% or the maximal 
depression of the single twitch response. The intubation was 
performed and assessed by a skilled anesthesiologist who 
had at least 3 yr experience and who was blinded to the group 
assignments. The intubation condition was assessed according 
to the scoring system described by Viby-Mogensen [8] (Table 1). 
Successful intubation was defined as a successful intubation 
condition when each score of three components were more 
than 2 points. Failed intubation was defined if any component 
showed less than 2 points.
    Anesthesia was maintained with 2-2.5 vol% of end-tidal 
sevoflurane in oxygen 50% and air 50% with positive pressure 
ventilation that maintained normocapnia. Fentanyl or 
remifentanyl was administrated supplementary via bolus or 
infusion. The blood pressure and heart rate were measured 
imme diately prior to administering the study drug (baseline), 
just before intubation, immediately after intubation and 1 
minute and 2 minutes after the intubation. 
    Statistical analysis was performed using the Statistical Package 
for Social Sciences statistical software (SPSS 12.0, Chicago, 
Ohio, USA). Chi-sqaure tests were used for categorical data 
such as gender or the intubation scoring and paired Student 
t-tests were used for the other continuous quantitative data. The 
data are reported as means ± SDs. The results were considered 
statistically significant when the P value was less than 0.05.
Results
    There was no statistical difference in age, weight or height 
between the groups. However, the number of females was 
higher than the number of male patients in both groups (Table 2). 
    The onset time of rocuronium in the phenylephrine group (P 
group) was significantly prolonged (about 17%) when compared 
with that in the saline group (S group) (Table 3). The duration 
of rocuronium were 41 ± 3 minutes in the P group and 43 ± 9 
minutes in the S group, and there was no significant difference 
(Table 3). In all the patients, intubation was successful at the 
first attempt and the intubation score was equal or greater than 
seven. 
    The mean arterial pressure was significantly decreased from 
baseline at just before intubation and at 1 minute and 2 minutes 
after the intubation (Fig. 2). The heart rate was significantly 
increased at 1 minute and 2 minutes after the intubation in both 
groups (Fig. 3). There were no significant differences in blood 
pressures or heart rates at each time before and after intubation 
between the two groups (Fig. 2 and 3). 
Table 1. Intubation Scoring System According to Viby-Mogensen [8] 
Score Vocal cord Jaw relaxation Coughing or bucking
3
2
1
0
Fully abducted
Slightly abducted
Partially abducted
Closed
Fully relaxed
Slightly stiff
Stiff
Impossible to open
Nil
Slight
Moderate
Severe
Table 2. Patients’ Characteristics 
S group (n = 34) P group (n = 30)
Age (yr) [range]
Weight (kg)
Height (cm)
Gender (M/F)
 40 ± 14 [15-59]
66 ± 20
161 ± 19
11/23
   40 ± 13 [16-65]
60 ± 10
164 ± 8
10/20
Values are means ± SD or the number. S group: normal saline 
administered 40 sec before rocuronium, P group: phenylephrine 0.9 
µg/kg administered 40 sec before rocuronium. 
Table 3. Comparison of the Onset Time and the Duration of Rocuronium
S group (n = 34) P group (n = 30)
Onset (sec)
Duration (min)
72 ± 14
43 ± 9
  84 ± 18*
41 ± 3
Values are means ± SD or the number. Onset: the time interval from 
the end of rocuronium injection to 0% or the maximal depression 
of a single twitch height, Duration: the time interval from the 
maximal depression of a single twitch to the 10% recovery of twitch 
heightfrom the end of rocuronium injection. S group: normal saline 
administered before rocuronium, P group: phenylephrine 0.9 µg/kg 
administered before rocuronium. *P = 0.003. 
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Discussion 
    This study demonstrated that the onset time of rocuronium 
was prolonged when the patients undergoing general 
anesthesia were pretreated with phenylephrine. There was no 
difference in the intubation condition or the duration of action 
of rocuronium between the two groups. 
    The onset time of a non-depolarizing muscle relaxant can 
be influenced by the potency of the agent itself, the injected 
dosage and circulation factors, which may influence its time 
course to the neuromuscular junction [1]. When ephedrine was 
pretreated in the previous studies, the intubating conditions 
were also improved in addition to reducing the onset time 
of rocuronium [9-11]. We can suggest the increased cardiac 
output was a likely cause because ephedrine stimulates the 
β-adrenergic accepter, which in turn may have assisted the 
rapid arrival of the muscle relaxant to the neuromuscular 
junction [2]. As an indirect evidence, Han et al. [7] reported that 
the introduction of rocuronium at the point when the cardiac 
output was increased by ephedrine effectively reduced the 
onset time. In addition, another study using esmolol, which 
is a β1-adrenergic antagonist, reported that the onset time of 
rocuronium was delayed when esmolol was introduced before 
the settlement of rocuronium. These studies support the fact 
that the effect of a β-adrenergic receptor agonist oriented by 
the ephedrine served a significant role in accelerating the onset 
time [2,5]. On the other hand, Herweling et al. [12] reported a 
debatable result in an animal study. In their study, although the 
introduction of ephedrine did increase the cardiac output and 
muscle blood flow, such outcomes failed to affect the onset time 
of rocuronium. They suggested a possibility that accelerated 
delivery of β-adrenergic receptor may not be the only cause of 
the reduced onset time of a muscle relaxant. 
    Since ephedrine exerts both α- and β-adrenergic agonist 
effects, stimulation of the α-adrenergic receptors may have 
influenced the change in the onset time of a depolarizing 
muscle relaxant by inducing vasoconstriction to increase 
the perfusion pressure to the organs. Phenylephrine, which 
is an α-adrenergic agonist, increases the blood pressure by 
contracting the medium-sized peripheral arteries and this 
maintains the cardiac output [13-15]. The increase in blood 
pressure caused by phenylephrine increases the muscle blood 
flow regardless of the contracted arteries [16]. Thus, we can 
hypothesize that the acceleration of α-adrenergic receptor via 
penylephrine may contribute to the shortening of the onset time 
of rocuronium. However, in this current study, phenylephrine 
prolonged the onset of rocuronium and it did not increase the 
blood pressure. Delayed onset of rocuronium’s action may 
be explained in part with delayed delivery of rocuronium to 
the neuromuscular junction by the α-adrenergic effect of 
phenylephrine. Another explanation for the delayed onset may 
be the dose of phenylephrine. The amount of phenylephrine 
(0.9 μg/kg) used in this study was not sufficient to prevent the 
decrease in perfusion to the adductor pollicis muscle during 
anesthesia induction. The dose of phenylephrine was chosen 
based on a previous study by Saravanan et al. [6], that 0.9 μg/
kg of phenylephrine has the same potency as ephedrine 70 μg/
kg [2,4], which was reported to cause little change in the blood 
pressure and heart rate according to the potency ratio of 80 : 1. 
    The onset time of rocuronium in the phenylephrine group was 
84 seconds, which was similar to that in the patients without 
any pretreatment in other studies [2,7]. It is assumed that the 
Fig. 2. The changes in the mean arterial pressure during induction. 
Pre-induction: just before fentanyl injection, S group: normal saline 
administered before rocuronium, P group: phenylephrine 0.9 μg/
kg administered before rocuronium. *P < 0.05 versus the mean pre-
induction value of the group. Vertical bar: standard deviation.
Fig. 3. The changes in the heart rate during induction. Pre-induction: 
just before fentanyl injection, S group: normal saline administered 
before rocuronium, P group: phenylephrine 0.9 μg/kg administered 
before rocuronium. *P < 0.05 versus the mean pre-induction value 
of the group. Vertical bar: standard deviation.
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types or amount of the anesthetic agent used during induction 
and racial differences may have affected this result. The onset 
time of rocuronium in the control group was 72 seconds, which 
was relatively short compared to that in other studies [4,5,7]. 
This result seems to be caused by the higher number of female 
patients in this study [17,18]. There are differences in terms 
of the pharmacodynamics of the drug used for anesthesia 
depending on gender and it has been reported that females 
were 20-30% more sensitive to muscle relaxant than males 
[17,18]. 
    There was no difference in the duration of rocuronium 
or the intubating condition between the two groups in this 
study. Since the intubation was conducted within 20 sec of 
the maximum twitch depression under the neuromuscular 
function-monitoring condition, this outcome was somewhat 
expected. 
    There are some limitations to this study. First, the hemo-
dynamic parameters such as cardiac output and systemic 
vascular resistance, which may ditermine the type of adrenergic 
effect, were not measured. Second, the muscle relaxation of 
the adductor pollicis muscle may not exactly reflect the muscle 
relaxation of the occipitalis muscle and diaphragm, which were 
related to the intubation. 
    In conclusion, a small dose of phenylephrine, which has 
a limited effect on blood pressure, delayed the onset time of 
rocuronium after the administration of propofol. These results 
suggest that the β-adrenergic agonist effect of ephedrine 
contributes to reducing the onset time of rocuronium by 
overcomeing the α-stimulating effect. 
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